Literature DB >> 8455352

Autosomal-dominant polycystic kidney disease in the rat.

B D Cowley1, S Gudapaty, A L Kraybill, B D Barash, M A Harding, J P Calvet, V H Gattone.   

Abstract

Kaspareit-Rittinghausen described a rodent model of inherited polycystic kidney disease (PKD), the Han:SPRD rat [1, 2], in which heterozygotes develop renal cysts and renal failure (in males) over several months, whereas homozygous animals develop rapidly progressive renal enlargement that leads to death in a few weeks. In this study, we examined selected elements of the pathogenesis of this disease in heterozygotes and homozygotes from birth to advanced disease. Heterozygous male rats developed slowly progressive renal cystic disease with interstitial fibrosis and azotemia seen by six months of age. Female heterozygotes developed slowly progressive renal cystic disease, but did not develop interstitial fibrosis or azotemia. Epithelial cells lining cyst cavities showed various degrees of morphologic immaturity. Cyst walls also developed basement membrane thickening, especially in areas of cellular immaturity, suggesting an interrelationship between this basement membrane thickening and cellular dedifferentiation. Thickened basement membranes were associated with increased immunoreactivity for type IV collagen, laminin, and fibronectin. Homozygous rats developed massive renal enlargement, marked azotemia, and died near three weeks of age. Renal c-myc proto-oncogene expression was elevated in homozygous cystic infants and in adult heterozygotes. In situ hybridization showed high levels of c-myc mRNA in cyst epithelia, suggesting abnormal regulation of cellular proliferation in the cells lining cysts, as seen in other models of PKD. The Han:SPRD rat is the only well-documented animal model of inherited PKD with an autosomal-dominant inheritance pattern and appears to have several features which resemble human ADPKD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455352     DOI: 10.1038/ki.1993.79

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  55 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.

Authors:  Xia Zhou; Lucy X Fan; Dorien J M Peters; Marie Trudel; James E Bradner; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

Review 3.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

4.  Calcimimetic inhibits late-stage cyst growth in ADPKD.

Authors:  Vincent H Gattone; Neal X Chen; Rachel M Sinders; Mark F Seifert; Danxia Duan; David Martin; Charles Henley; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

5.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

6.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

7.  Pathogenesis of arrhythmias in a model of CKD.

Authors:  Chia-Hsiang Hsueh; Neal X Chen; Shien-Fong Lin; Peng-Sheng Chen; Vincent H Gattone; Matthew R Allen; Michael C Fishbein; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

8.  Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.

Authors:  Matthew R Allen; Neal X Chen; Vincent H Gattone; Sharon M Moe
Journal:  Am J Nephrol       Date:  2013-11-22       Impact factor: 3.754

9.  Primary cilia disruption differentially affects the infiltrating and resident macrophage compartment in the liver.

Authors:  Kurt A Zimmerman; Cheng Jack Song; Nancy Gonzalez-Mize; Zhang Li; Bradley K Yoder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

10.  Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.

Authors:  M R Allen; N X Chen; V H Gattone; X Chen; A J Carr; P LeBlanc; D Brown; S M Moe
Journal:  Osteoporos Int       Date:  2012-08-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.